{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Abbott", "item": "https://www.patentleaderboard.com/2021/company/abbott"}, {"@type": "ListItem", "position": 4, "name": "Jieyi Wang", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ji_ln:wang-137"}]}

Home › 2021 › Abbott › Jieyi Wang

Jieyi Wang — 3 Patents in 2021

LLLyvgen Biopharma Holdings Limited: 3 patents #1 of 4Top 25%

Belmont, CA: #45 of 344 inventorsTop 15%

California: #8,414 of 66,859 inventorsTop 15%

Overall (2021): #77,940 of 548,734Top 15%

3 Patents 2021

Issued Patents 2021

Showing 1–3 of 3 patents

Patent #	Title	Co-Inventors	Date
11203643	Humanized anti-CD137 antibodies and uses thereof	Yi-Ting Wu	2021-12-21
11186648	Anti-CD40 antibody having engineered Fc domains and therapeutic uses thereof	Yi-Ting Wu	2021-11-30
10913797	Anti-PD-1 antibodies and therapeutic uses thereof	Liqun Dong, Yaolin Wang	2021-02-09

Jieyi Wang — 3 Patents in 2021

Issued Patents 2021

Patent Widget